MENU

What is Stroke Medicines Access Program?

     The Department of Health (DOH) in collaboration with the Stroke Society of the Philippines (SSP) under the leadership of Dr. Ma. Cristina San Jose and Jose R. Reyes Memorial Medical Center (JRRMMC) lead by Dr. Jose Navarro, implements the DOH-Stroke Medicines Access Program (StrokeMAP) in February 2016. The Program aims to make Human Recombinant Tissue Type Plasminogen Activator or Alteplase be accessible to all clinically eligible stroke patients in all participating DOH hospitals.

     In this program, the DOH will seek not only issue on the unavailability of essential medicines in government hospitals but also to bring down the prices of drugs. The DOH procured 1,043 vials projecting a year supply of this innovative medicine. Alteplase in private hospitals costs as much as Php 80,000.00 per vial while in public hospitals the said drug costs Php 50,000.00 Pursuant to the Cheaper Medicines Act of 2008, allowing the DOHexert its effort through price negotiation with innovative companies to allow access of the poor to expensive patented medicines.

     The DOH, JRRMMC and SSP have also conducted training program prior to the delivery of the said medicine to all healthcare providers involved in the StrokeMAP to make sure that this will be administered correctlyto patients based on the standard protocol

Goal

To improve health outcomes of all clinically eligible patients suffering from acute ischemic stroke.

Objectives

  1. To provide access to Human Immunoglobulin for Kawasaki disease patients especially the poor Filipino children
  2. To prevent further complications like coronary abnormalities (heart damage)
  3. To reduce mortality rate especially among children.

How to avail the program?

 

     The following steps are the critical period of the treatment. Alteplase must be administered within 4 hours of stroke onset:

Signs of possible stroke – F.A.S.T.

F – Face Drooping

A – Arm Weakness

S – Speech Difficulty

T – Time is Brain. Go to the hospital immediately

List of Access sites and List of Medicine included in the program

1. East Avenue Medical Center 18. Caraga Regional Hospital
2. Novaliches District Hospital 19. Bataan General Hospital
3. Philippine Heart Center 20. Dr. Paulino J. Garcia Memorial Research & Medical Center
4. Jose R. Reyes Memorial Medical Center 21. Batangas Medical Center
5. National Kidney and Transplant Institute 22. Bicol Regional Training and Teaching Hospital
6. Quirino Memorial Medical Center 23. Bicol Medical Center
7. Las Piñas General Hospital and Satellite Trauma Center 24. Gov. Celestino Gallares Memorial Hospital
8. Philippine General Hospital 25. Vicente Sotto Memorial Medical Center
9. Ilocos Training and Regional Medical Center 26. Corazon Locsin Montelibano Memorial Regional Hospital
10. Region I Medical Center 27. Western Visayas Medical Center
11. Mariano Marcos Memorial Medical Center 28. Western Visayas State University Medical Center
12. Baguio General Hospital and Medical Center 29. Zamboanga City Medical Center
13. Cagayan Valley Medical Center 30. Cotabato Regional and Medical Center
14. St. Paul Hospital, Cagayan Valley 31. Northern Mindanao Medical Center
15. Divine Mercy Wellness Hospital, Cagayan Valley 32. Amai Pakpak Medical Center
16. Southern Isabela General Hospital 33. Mayor Hilarion A. Ramiro Sr. Regional & Teaching Hospital
17. Jose B. Lingad Memorial Regional Hospital 34. Southern Philippines Medical Center

Medicine Included in the Program

1. Human Recombinant Tissue Type Plasminogen Activator or Alteplase 50 mg vial

What is Kawasaki Disease Medicines Access Program?

     Kawasaki disease is a rare condition which is common in children less than 5 years old and of Asian descent. Approximately 20% of cases will lead to coronary aneurysms if left untreated, which can cause myocardial infarction in the young. Inflammation of the coronary arteries, heart muscle, lining, valves, and the outer membrane around the heart may occur which can lead to death. However, if symptoms are detected in the first ten (10) days of illness, patients have a high chance of recovery with a decreased risk for a coronary aneurysm.

     Human Immunoglobulin (IVIG), the medicine that is widely used to reduce the risk of damage to the coronary arteries of the heart, costs more than the salary of an ordinary Filipino minimum wage earner. Non-compliance due to poor access to medicine contributes to the increasing number of Kawasaki Disease cases in the country. This is classified as an essential drug included in the current edition of the Philippine National Formulary (PNF) but there has been a wide gap in making the medicine accessible to patients because of its prohibitive cost.

     To improve access to this life-saving medicine that will help reduce the mortality rate among children and will improve their health outcomes, the Pharmaceutical Division (PD) under the Office for Health Regulation has collaborated with the Philippine Heart Center (PHC) to develop the Kawasaki Disease Medicines Access Program (KDMAP), which shall provide human immunoglobulin (IVIG) to all patients suffering from the said condition in selected government hospitals nationwide.

Goal

To improve health outcomes of Filipino patients suffering from Kawasaki Disease

Objectives

  1. To provide access to Human Immunoglobulin for Kawasaki disease patients especially the poor Filipino children
  2. To prevent further complications like coronary abnormalities (heart damage)
  3. To reduce mortality rate especially among children.

List of Access Sites

1. Philippine Heart Center 19. Jose B. Lingad Memorial Regional Hospital
2. Philippine Children's Medical Center 20. Batangas Medical Center
3. National Children's Hospital 21. Bicol Regional Training and Teaching Hospital
4. Rizal Medical Center 22. Bicol Sanitarium
5. Jose R. Reyes Memorial Medical Center 23. Bicol Medical Center
6. East Avenue Medical Center 24. Corazon Locsin Montelibano Memorial Regional Hospital
7. Research Institute for Tropical Medicine 25. Western Visayas Medical Center
8. Las Piñas General Hospital and Satellite Trauma Center 26. Don Emilio Del Valle Memorial Hospital
9. Quirino Memorial Medical Center 27. Vicente Sotto Memorial Medical Center
10. Ilocos Training and Regional Medical Center 28. Gov. Celestino Gallares Memorial Hospital
11. Region I Medical Center 29. Eversley Childs Sanitarium
12. Mariano Marcos Memorial Hospital and Medical Center 30. Eastern Visayas Regional Medical Center
13. Baguio General Hospital and Medical Center 31. Zamboanga City Medical Center
14. Cagayan Valley Medical Center 32. Sulu Sanitarium
15. Veterans Regional Hospital 33. Mayor Hilarion A. Ramiro Sr. Regional Training and Teaching Hospital
16. Bataan General Hospital 34. Northern Mindanao Medical Center
17. Dr. Paulino J. Garcia Memorial Research and Medical Center 35. Southern Philippines Medical Center
18. Talavera Extension Hospital

The following are the medicines included in the program:

1. Human Immunoglobulin 50 mg/mL, 50 mL vial

2. Human Immunoglobulin 50 mg/mL, 100 mL vial

Program Background

     Pursuant to Republic Act 9502, the Department of Health through the National Center  for  Pharmaceutical Access  and  Management (NCPAM)  is  tasked  to pursue a medicines access program including geriatric healthcare nationwide. This will address the needs of the elderly/senior citizens focused on their overall health needs including their medicines requirements.

     The GERIATRIC HEALTH MEDICINES ACCESS PROGRAM (GHMAP) was developed to address the needs to support the first ever GERIATRIC HOSPITAL in the country through the inauguration of the Eva Macaraeg-Macapagal National Center for Geriatric Health or formerly known as the Singian Hospital located along Malacañang, Manila in 2010.  The Center was under the management of the Jose R. Reyes Memorial Medical Center (JRRMMC), since the House Bill for the establishment of this Center is still pending in the Congress.

What is Valsartan Acess Program

     The Doh has concluded negotiations and discussion with Novartis Philippines having entered into a Memorandum of Understanding (MOU) dated May 28, 2009 under the MOU, Novartis will grant non-exclusive right to DOH market, promote and sell the Valsartan products under the mark "DOH Valsartan" in all DOH Hospitals and some Local Government Units (LGUs) pharmacies.

     Valsartan provides blood pressure (BP) reductions that last a full 24 hours greater with increasing baseline systolic BP and across diverse patients types and it is available at strengths of Valsartan 80 mg and Valsartan 160 mg film-coated tablets. This anti-hypertensive drug is still under patent until 2014 and has offered 50-60% cheaper compared to the prevailing market price.

     Thirty (30) DOH Retained Hospital and two (2) Provincial Health Offices (PHOs) participated in the first initial orders of Valsartan 80 mg and 160 mg film-coated tablets.

What is Insulin Access Program?

     The Department of Health (DOH) established the Insulin Medicines Access Program (InMAP), which was developed through a Private-Public Partnership (PPP) wherein the innovator company voluntarily offered their products at a much reduced affordable price to the DOH hospitals.

     The access program for insulin was being implemented through a consignment system in 27 DOH hospitals where only a limited number of patients, have benefited from the program.  In order to expand and reach out to the poorest sector, the DOH will now be providing insulin for all indigent diabetic patients at no cost to them. Free insulin access will be implemented in DOH Hospitals nationwide and City Health Offices

Goal

To improve health outcomes of Filipino patients suffering from Diabetes

Objectives

  1. To provide access to Insulin for all diagnosed insulin-dependent diabetic patients and non-insulin dependent diabetic patients who no longer respond to oral medication or who require insulin administration particularly with limited financial resources as assessed by the hospital medical social worker and PhilHealth sponsored patients.
  2. To prevent long-term complications such as blindness, neuropathy (nerve damage), cardiovascular disease, stroke, kidney failure, among others

How to Avail the Program

     Present your prescription and valid ID to the Hospital Pharmacy to avail monthly supply of insulin

List of Access Sites and Insulin Products

List of Access Sites

1. Adela Serra Ty Memorial Medical Center

27. Mariano Marcos Memorial Hospital

2. Amai Pakpak Medical Center

28. Mayor Hilarion Ramiro Sr., Reg’l. Training & Teaching Hospital

3. Amang Rodriguez Memorial Medical Center

29. National Center for Mental Health

4. Baguio General Hospital and Medical Center

30. National Children's Hospital

5. Bataan General Hospital

31. National Kidney and Transplant Institute

6. Bicol Medical Center

32. Philippine Children's Medical Center

7. Batangas Medical Center

33. Philippine Heart Center

8. Bicol Regional Training and Teaching Hospital

34. Regional I Medical Center

9. Cagayan Valley Medical Center

35. Rizal Medical Center

10. CARAGA Regional Hospital

36. San Lorenzo Ruiz Women's Hospital

11. Corazon Locsin Montelibano Memorial Regional Hospital

37. Schistosomias Control and Research Hospital

12. Cotobato Sanitarium

38. St. Anthony Mother and Child Hospital

13. Davao Regional Hospital

39. Talavera Extension Hospital

14. Dr. Jose N. Rodriguez Memorial

40. Talisay District Hospital

15. Dr. Jose Rizal Memorial Hospital

41. Tondo Medical Center

16. Dr. Paulino J. Garcia Memorial Research and Medical Center

42. Valenzuela Medical Center

17. East Avenue Medical Center

43. Veterans Regional Hospital

18. Eastern Visayas Regional Medical Center

44. Vicente Sotto Sr. Memorial Medical Center

19. Eversley Childs Sanitarium

45. Western Visayas Medical Center

20. Gov. Celestino Gallares Memorial Hospital

46. Don Jose Monfort Medical Center Extension Hospital

21. Don Emilio Del Valle Memorial Hospital

47. Western Visayas Sanitarium

22. Ilocos Training and Regional Medical Center

48. Zamboanga City Medical Center

23. Jose R. Reyes Memorial Medical Center

49. Pasig City Health Office

24. Las Piñas General Hospital and Satellite Trauma Center

50. Pasig City Health Office         

25. Lung Center of the Philippines

51. Navotas City Health Office

26. Margosatubig Regional Hospital

The following are the insulin products included in the program:

1. Regular Insulin100 IU/mL, 10 mL vial

2. Isophane Insulin Human 100 IU/mL, 10 mL vial

3. Biphasic Isophane Insulin Human 100 IU/mL, 10 mL vial